When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off-label use by celebrities and social media influencers for cutting weight ...

Commercial insurance coverage of blockbuster GLP-1 drugs has not expanded much over the past year, despite growing demand and expanded indications, according to a new report from GoodRx. Data from ...

and GLP-1 agonists — was affected by the age or sex of people with type 2 diabetes. People in the 592 HbA1c trials had a mean age of 58.9 years (42.3% female), and for the 23 trials that ...

The cohorts were propensity score matched on the basis of baseline demographic characteristics, comorbidities, and use of medication, resulting in 61,057 patients receiving GLP-1 RAs (mean age ...